Received Jan 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Sore arm; Patient felt off; Headaches; This non-serious case was reported by a consumer via sales rep and described the occurrence of pain in arm in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, less than a day after receiving Boostrix, the patient experienced pain in arm (Verbatim: Sore arm), feeling abnormal (Verbatim: Patient felt off) and headache (Verbatim: Headaches). The outcome of the pain in arm, feeling abnormal and headache were unknown. It was unknown if the reporter considered the pain in arm, feeling abnormal and headache to be related to Boostrix. It was unknown if the company considered the pain in arm, feeling abnormal and headache to be related to Boostrix. Additional Information: GSK Receipt Date: 29-DEC-2025 The reporter mentioned that the patient experienced sore arm on the day of the vaccination in the evening (day 1), next day (day 2) the patient felt off and on day 3 the patient experienced headaches. The batch number was not provided, and unable to contact the reporter.